Author:
Georgoulias V,Agelidou A,Syrigos K,Rapti A,Agelidou M,Nikolakopoulos J,Polyzos A,Athanasiadis A,Tselepatiotis E,Androulakis N,Kalbakis K,Samonis G,Mavroudis D
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Agelaki S, Bania H, Kouroussis Ch, Blazoyiannakis G, Souglakos J, Tsiafaki X, Kalbakis K, Rapti A, Androulakis N, Georgoulias V, Papadakis E (2001) Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study. Lung Cancer 34 (Suppl 4): 77–80
2. Androulakis N, Kouroussis CH, Kakolyris S, Tzannes S, Papadakis E, Papadimitriou C, Geroyianni A, Georgopoulou T, Dimopoulou I, Souglakos J, Kotsakis A, Vardakis N, Hatzidaki D, Georgoulias V (1998) Salvage treatment with paclitaxel and gemcitabine for patients with non-small cell lung cancer after cisplatin- or docetaxel-based chemotherapy: a multicenter phase II study. Ann Oncol 9: 1127–1130
3. Belani CP (1993) Multimodality management of regionally advanced non-small cell lung cancer. Semin Onco 20: 302–314
4. Belani CP (1998) Single agents in the second-line treatment of non-small cell lung cancer. Semin Oncol 25 (3, Suppl 8): 10–14
5. Boisseau M, Guichard S, Canal P (1996) Irinotecan (CPT-11): current status and perspectives. Exp Opin Invest Drugs 5: 613–626
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献